Currently, therapeutic strategies against obesity have been largely ineffective, such as 5-hydroxytryptamine modulators, β3 adrenoceptor agonists, lipase inhibitors, melanocortin 4 inhibitors, leptin agonists and ghrelin antagonists [10]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.